The case of the Crumbling Spine Flashcards
Fragility fracture?
Fragility fracture
fracture caused by fall from standing height or less or spontaneous
Causes of Fragility Fractures (4)
reduced bone mineral density
altered bone architecture
changed bone material properties
treatment non-adherence
how do we measure bone mineral density?
how do we measure bone mineral density? bone densitometry (DEXA)
how do we evaluate bone architecture?
how do we evaluate bone architecture?
trabecular bone score
high res peripheral CT
what bone materials can change causing fragility fractures?
type 1 collagen
hydroxyapatite crystals
what bone materials can change causing fragility fractures?
get advanced glycation end products which can damage collagen
how can collagen be linked to fragility fractures?
mutations causing not enough or abnormal collagen
Bone remodelling cycle
Quiescence, resorption, reversal, formation
osteoclast action
resorption of bone
How are osteoblasts activated?
growth factors are released by osteoclasts
how do oestoblasts and osteoclasts change in menopause?
osteoclasts become more active than osteoblasts
How are osteoclasts activated?
RANKL from osteoblasts binds and causes osteoclast precursors to mature
Osteoprotegerin (OPG)
decoy receptor
blocks binding of RANK to RANK-L > reduces osteoclast differentiation
increases bone density
How does menopause cause osteoporosis?
reduced oestrogen causes reduced Osteoprotegerin expression
osteoclasts more active
mechanism of demosumab
decoy receptor for RANKL, mimics action of OPG
how is demosumab administered?
6 monthly injection
sclerostin
Made by osteocytes and suppresses bone formation
Wnt pathway in osteoporosis
canonical wnt pathway enhances osteoblast differentiation, upregulates OPG and down regulates RANKL
mechanism of romosozumab
antisclerostin antibody so enables Wnt system to remain active
get bone rebuilding
2 monoclonal antibodies used in the treatment of osteoporosis
denosumab
romosozumab
grancalcin
a protein that represses osteogenesis
what secretes grancalcin?
senescent immune cells
Osteoporosis
disorder of bone characterised by low bone mass and microarchitectural deterioration, increased fracture risk
primary osteoporosis type 1
postmenopausal, accelerated decrease in bone mass that occurs when estrogen falls
primary osteoporosis type 2
senile
affects men and women>70 yo
Primary osteoporosis T1 vs T2
postmenopausal, accelerated decrease in bone mass that occurs when estrogen falls = t1
senile
affects men and women>70 yo = t2